; and Encouragement of Verification, Innovation, Cleaning, and Efficiency Act of 2017 or the DEVICE Act of 2017 . 2. Reporting requirement for design and reprocessing instruction changes (a) Adulteration Section 501 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 351 ) is amended by inserting after paragraph (j) the following: (k) If it is a device with respect to which the manufacturer is in violation of the reporting requirement in section 510(q) (relating to design and reprocessing changes). . (b) Requirement Section 510 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360 ) is amended by adding at the end the following: (q) Reporting requirement for device design changes Before making a change to the design of a device, or the reprocessing instructions of a device, that is marketed in interstate commerce, the manufacturer of the device shall give written notice of the change to the Food and Drug Administration. . 3. Reporting requirement for certain communications to foreign health care providers (a) Adulteration Section 501 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 351 ), as amended by section 2 of this Act, is further amended by inserting after paragraph (k) the following: (l) If it is a device with respect to which the manufacturer is in violation of the reporting requirement in section 510(r) (relating to communications to foreign health care providers). . (b) Requirement Section 510 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360 ), as amended by section 2 of this Act, is further amended by adding at the end the following: (r) Reporting requirement for certain communications to foreign health care providers (1) Requirement The manufacturer of a device that is marketed in interstate commerce shall give written notice to the Food and Drug Administration of any communication described in paragraph (2) not more than 5 calendar days after making such communication. (2) Communication described A communication is described in this paragraph if the communication— (A) is